FDA Inspection 1162330 — UCLA Health, Component Processing Laboratory, Hematologic Malignancies/Stem Cell Transplantation Program
The FDA completed an inspection of UCLA Health, Component Processing Laboratory, Hematologic Malignancies/Stem Cell Transplantation Program on Feb 10, 2022 in Los Angeles, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 10, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Los Angeles, CA (United States)